A. Sampalo et al., Chronic lymphocytic leukemia B cells inhibit spontaneous Ig production by autologous bone marrow cells: role of CD95-CD95L interaction, BLOOD, 96(9), 2000, pp. 3168-3174
A variable degree of humoral immunodeficiency is a common feature in patien
ts with B-cell chronic lymphocytic leukemia (B-CLL), The aim of this study
was to explore the possibility that B-CLL cells play a direct role in this
phenomenon. To this end, patients' bone marrow (BM) immunoglobulin (Ig)-sec
reting cells were cocultured with autologous purified B-CLL cells. The resu
lts show that tumoral cells inhibited the spontaneous IgG secretion by BM p
lasma cells, and this effect increased after PMA-induction of B-CLL cells.
This inhibitory process was proportional to the number of B-CLL cells added
and depended on cellular contact. Adhesion molecules did not appear to be
involved in the cellular interaction, because the inclusion of blocking ant
ibody to a variety of these proteins did not reverse the inhibitory phenome
non. However, the addition of monoclonal antibody that blocked the function
of either CD95 or CD95L clearly reversed B-CLL cell inhibition on autologo
us BM plasma cells. These latter cells were shown to express CD95, and B-CL
L cells contained detectable quantities of CD95L at the level of messenger
RNA and protein. Annexin V-binding experiments revealed increased apoptosis
of BM Ig-secreting cells when cocultured with autologous B-CLL cells. Fina
lly, this inhibitory phenomenon might be operative in vivo because (a) ther
e was a good correlation between the intensity of the inhibitory effect in
vitro and the serum IgG level exhibited by every patient and (b) B-CLL cell
s also inhibited in vivo antigen-induced IgG-tetanus toroid-secreting cells
obtained from normal Immunized subjects. Collectively, these data suggest
that B-CLL cells inhibit autologous CD95-bearing Ig-secreting cells by the
interaction with CD95L present on B-CLL cells and, hence, contribute to the
state of humoral immunodeficiency that occurs in these patients. (C) 2000
by The American Society of Hematology.